The first line of therapy is typically medication, which either relaxes the prostate or shrinks it, according to Dr. Kaminetsky. But either class of medication can have sexual side effects, including erectile dysfunction or a decreased libido and orgasm, he said. Some medical procedures also carry the risk of sexual side effects, Dr. Kaminetsky said.
“The procedure I'm most excited about is called the iTind… It’s a temporary implant that we put into the prostate...,” he said. “What it does it is it remodels the prostate and gets very close to surgical results with no sexual side effects.”
The iTind is made up of three flexible nitinol (nickel titanium super alloy) struts that gently expand over a five- to seven-day period and does not require an overnight hospital stay. The temporary device is placed in the prostatic urethra during a procedure that can be done in a medical office. iTind reshapes the prostate by gently exerting pressure on the tissue to open three channels, allowing urine to flow and relieving lower urinary tract symptoms (LUTS) without the need for most patients to go home with a catheter.
A studyii has shown that the iTind procedure preserves sexual function for men with an enlarged prostate, and without a permanent implant, the procedure does not hamper any future treatment options. Implantation of the iTind device may cause urinary urgency, pelvic discomfort, dysuria or hematuria. In rare cases, iTind may cause urinary tract infection or acute urinary retention.
Dr. Kaminetsky urged men to take advantage of the treatment options available and reminded those in their lives to keep an eye out for warning signs of an enlarged prostate.
“If you see your friend or partner is running to the bathroom more than he should, or even if he’s not, he should every year come and get a prostate check and get his PSA (prostate-specific antigen) checked and make sure he doesn’t have prostate cancer,” Dr. Kaminetsky said.
"Don’t suffer silently.”
iUrologyhealth.org, Urology A-Z
iiChughtai B, Elterman D, Shore N, et al. The iTind Temporarily Implanted Nitinol Device for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A Multicenter, Randomized, Controlled Trial [published online ahead of print, 2020 Dec 26]. Urology. 2020; S0090-4295(20)31520-X. DOI: 10.1016/j.urology.2020.12.022